Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimation of SARS-CoV-2 aerosol emissions from simulated patients with COVID-19 and no to moderate symptoms

View ORCID ProfileMichael Riediker, View ORCID ProfileDai-Hua Tsai
doi: https://doi.org/10.1101/2020.04.27.20081398
Michael Riediker
1Swiss Centre for Occupational and Environmental Health, Winterthur, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Riediker
Dai-Hua Tsai
1Swiss Centre for Occupational and Environmental Health, Winterthur, Switzerland
2Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dai-Hua Tsai
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Cases of the coronavirus disease 2019 (COVID-19) with no or mild symptoms were reported to frequently transmit the disease even without direct contact. The severe acute respiratory syndrome virus (SARS-COV-2) was found at very high concentrations in swab and sputum of such cases.

Objective We aimed to estimate in a mathematical modeling study the virus release from such cases into different aerosol sizes by normal breathing and coughing, and what exposure can result from this in a room shared with such as case.

Data Sources and Model We combined the size-distribution of exhaled breath microdroplets for coughing and normal breathing with viral sputum concentrations as approximation for lung lining liquid to obtain an estimate of emitted virus levels. The resulting emission data fed a single-compartment model of airborne concentrations in a room of 50 m3, the size of a small office or medical exam room.

Results The estimated viral load in microdroplets emitted by simulated patients while breathing normally was on typical 0.0000049 copies/cm3 and could go up to 0.637 copies/cm3. The corresponding numbers for coughing simulated patients were 0.277 copies/cm3 and 36,030/cm3, respectively, per cough. The resulting concentrations in a room with a coughing emitter were always very high, up to 7.44 million copies/m3. However, also regular breathing microdroplets from high emitters was modelled to lead to 1248 copies/m3.

Conclusions and Relevance In this modelling study, breathing and coughing were estimated to release large numbers of viruses, ranging from thousands to millions of virus copies/m3 in a room with an emitter having a high viral load, depending on ventilation and microdroplet formation process. These findings suggest that strict respiratory protection may be needed when there is a chance to be in the same room with a patient - whether symptomatic or not - especially for a prolonged time.

Question How much SARS-CoV-2 virus is released from a case by breathing and coughing, and what is the resulting concentration in a room?

Finding In this mathematical modelling study, both, breathing and coughing were estimated to release large numbers of viruses, which can lead to millions of virus copies/m3 in a poorly ventilated room with a coughing emitter.

Meaning These results may explain the important rate of transmissions and implies the need for strict respiratory protection when people are in the same room with a case with COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This modelling was entirely funded by the Swiss Centre for Occupational and Environmental Health (SCOEH).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This mathematical modelling corresponds to a meta-analysis. We used aggregate data from previous clinical studies in which informed consent had already been obtained by the trial investigators; therefore, our study was exempt from ethics approval, according to the Common Rule.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data sources are mentioned in the manuscript and publicly available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted July 07, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimation of SARS-CoV-2 aerosol emissions from simulated patients with COVID-19 and no to moderate symptoms
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimation of SARS-CoV-2 aerosol emissions from simulated patients with COVID-19 and no to moderate symptoms
Michael Riediker, Dai-Hua Tsai
medRxiv 2020.04.27.20081398; doi: https://doi.org/10.1101/2020.04.27.20081398
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Estimation of SARS-CoV-2 aerosol emissions from simulated patients with COVID-19 and no to moderate symptoms
Michael Riediker, Dai-Hua Tsai
medRxiv 2020.04.27.20081398; doi: https://doi.org/10.1101/2020.04.27.20081398

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Occupational and Environmental Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)